Evaluation of the in vitro antileishmanial activities of bioactive guided fractionations of two medicinal plants
- PMID: 33612714
Evaluation of the in vitro antileishmanial activities of bioactive guided fractionations of two medicinal plants
Abstract
The organisms of the genus Leishmania are flagellated protozoan parasites and are the causative agents of leishmaniasis. This disease is a major health problem, especially in tropical countries. Currently, cutaneous leishmaniasis is treated by chemotherapy using pentavalent antimonials, but these drugs have serious organo-toxicity, drug resistance on several occasions, and low efficiency in controlling the infection. The present work is carried out to evaluate the in vitro antileishmanial activity of methanolic extracts and phytochemical fractions of two plants ethnobotanically used against leishmaniasis and skin infection, Calotropis procera and Rhazya stricta leaves against Leishmania major promastigote and amastigote stages and cytotoxicity against the Vero cell line. The leaves of C. procera and R. stricta were extracted with methanol and fractionated by petroleum ether, chloroform, ethyl acetate, n-butanol, and water. The methanolic extracts of the leaves of C. procera and R. stricta exhibited antileishmanial activity against L. major promastigotes with IC50 values of 66.8 and 42.4 µg mL-1, respectively. While their CC50 2.3 and 298 µg mL-1 and their SI 0.03 and 7.03 respectively. However, the fractionations of the methanolic extract of C. procera leaves revealed antiparasitic activity against both L. major promastigote and amastigote stages in vitro, which significantly increased with polarity with the exception of n-butanol. Hence the best activity was revealed by the water fraction (IC50 of 26.3 and 29.0 µg mL-1) for the two stages. In conclusion, further phytochemical investigation should be performed for the C. procera water extract in terms of antileishmanial active ingredient isolation that may enhance the possibility of avoiding toxic substances and overcome the low SI (1.1 and 1.01).
Similar articles
-
Assessment of Euphorbia retusa and Pulicaria undulata activity against Leishmania major and Toxoplasma gondii.Trop Biomed. 2021 Mar 1;38(1):135-141. doi: 10.47665/tb.38.1.023. Trop Biomed. 2021. PMID: 33797536
-
Antileishmanial Activities of Medicinal Herbs and Phytochemicals In Vitro and In Vivo: An Update for the Years 2015 to 2021.Molecules. 2022 Nov 4;27(21):7579. doi: 10.3390/molecules27217579. Molecules. 2022. PMID: 36364404 Free PMC article. Review.
-
In Vitro Anti-Leishmanial Assessment of Some Medicinal Plants Collected from Al Qassim, Saudi Arabia.Acta Parasitol. 2020 Sep;65(3):696-703. doi: 10.2478/s11686-020-00205-2. Epub 2020 Apr 28. Acta Parasitol. 2020. PMID: 32347535
-
Antiplasmodial efficacy of Calotropis gigantea (L.) against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA).J Vector Borne Dis. 2017 Jul-Sep;54(3):215-225. doi: 10.4103/0972-9062.217612. J Vector Borne Dis. 2017. PMID: 29097636
-
Medicinal plants with promising antileishmanial activity in Ethiopia: A systematic review and meta-analysis.Medicine (Baltimore). 2024 May 31;103(22):e38480. doi: 10.1097/MD.0000000000038480. Medicine (Baltimore). 2024. PMID: 39259058 Free PMC article.
Cited by
-
Anti-Leishmania major activity of Calotropis procera extract by increasing ROS production and upregulating TNF-α, IFN-γ and iNOS mRNA expression under in vitro conditions.Trop Med Health. 2024 Feb 1;52(1):16. doi: 10.1186/s41182-024-00578-4. Trop Med Health. 2024. PMID: 38303082 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources